CN1689637A - Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process - Google Patents
Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process Download PDFInfo
- Publication number
- CN1689637A CN1689637A CN 200510056634 CN200510056634A CN1689637A CN 1689637 A CN1689637 A CN 1689637A CN 200510056634 CN200510056634 CN 200510056634 CN 200510056634 A CN200510056634 A CN 200510056634A CN 1689637 A CN1689637 A CN 1689637A
- Authority
- CN
- China
- Prior art keywords
- filtrate
- filter
- adds
- radix salviae
- salviae miltiorrhizae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is one kind of Chinese medicine preparation for treating cardiac and cerebral vascular diseases and its preparation process. The Chinese medicine preparation is prepared with red sage and ginkgo leaf. Compared with available technology, the Chinese medicine preparation has simple and reasonable recipe, high curative effect, no toxic side effect, and different preparation forms for wide application. The Chinese medicine preparation can improve metabolism of myocardial and cerebral tissue, increase blood flow of coronary artery and cerebral blood vessels, improve the blood supply of myocardial and cerebral tissue, etc. and thus high curative effect on cardiac and cerebral vascular diseases, such as coronary heart disease, angina pectoris, arrhythmia, etc. In addition, it can raise immunity and disease resistance.
Description
Technical field: the present invention is a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof, belongs to technical field of Chinese medicine.
Technical background: cardiovascular and cerebrovascular disease such as coronary heart disease, cerebral thrombosis, alzheimer disease etc. all are one of the most common and diseases that harm is maximum in the world today, have become human mortality's one of the main reasons in many countries; Prevent and treat purpose in order to reach, a large amount of research has been done by many inventors and medicine enterprise, and the product of some treatments also is provided; As: number of patent application is: 98110756.7, name is called " compound gingko leaf preparation and preparation method " and number of patent application is: 01129112.5, name is called " Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease and preparation method thereof " these two kinds of products and is and treats this type of disease and develop, but, dosage form kind in these two kinds of products is single, the simple inadequately refine of compatibility, under the situation of same effect, use too much raw material only can increase difficulty, the increase production management cost of quality control, even influence the result of use of medicine.Though researcher is arranged effective ingredient or the effective site of Radix Salviae Miltiorrhizae, Semen Ginkgo are made preparation, but single active ingredient and effective site can not be equal to medicament composing prescription, because the composition of Chinese medicine is very complicated, being by the overall coordination onset, is not that single active ingredient and effective site can be alternate.Though red sage formulation, ginkgo agent are arranged, the curative effect of using is not ideal enough separately; If both preparations are united use, very inconvenient again, but both prescription compatibilities do not appear in the newspapers.In view of such circumstances, seek that a kind of medical material compatibility is reasonable, therapeutic effect is desirable, the thing that does not have effective medicine of toxic and side effects just to become people to be badly in need of solving.
Summary of the invention: the objective of the invention is to: a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof is provided; The present invention is directed to prior art, according to cardiovascular and cerebrovascular disease such as coronary heart disease, cerebral thrombosis, alzheimer disease etc. all contract because of blood vessel is narrow, reason such as blood flow minimizing causes the diseases induced principle of blood supply insufficiency, adopts Folium Ginkgo and Radix Salviae Miltiorrhizae compatibility to make preparation; Wherein: Folium Ginkgo has blood vessel dilating, blood flow increasing, blood viscosity lowering, accelerates blood flow rate, anti-hypoxia and antiphlogistic effect; And Radix Salviae Miltiorrhizae has the effect of blood vessel dilating, arrhythmia, anti-hypoxia, protection cardiac muscle, shock, arteriosclerosis and enhancing immunity; Two medicines are worked in coordination with and are produced activating blood circulation to dissipate blood stasis, TONGMAI SHULUO, improve blood circulation and metabolism.For example coronary heart disease is that coronary atherosclerosis causes myocardial ischemia, anoxia and the heart disease that causes, and two medicines share, and can play to improve the myocardial metabolism effect, increase coronary flow, and the blood that improves cardiac muscle is provided with the effect of allevating angina pectoris.The present invention is reasonable for compatibility, and is simple; And the present invention is pure Chinese medicinal preparation, but the little patients life-time service of its untoward reaction.
The present invention constitutes like this: the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease: calculate according to parts by weight, it is made through extracting refining and adding suitable adjuvant by 80～20 parts of 20～80 parts of Radix Salviae Miltiorrhizaes and Folium Ginkgos; It also can be to be formed by corresponding weight portion medical material Radix Salviae Miltiorrhizae extract that obtains after extracting and the prepared from extraction of ginkgo leaves that corresponding weight portion medical material obtains after extraction.
Say accurately: calculate according to parts by weight, it is made for 60 parts with Folium Ginkgo by 50 parts of Radix Salviae Miltiorrhizaes, or is formed by corresponding weight portion medical material Radix Salviae Miltiorrhizae extract that obtains after extracting and the prepared from extraction of ginkgo leaves that corresponding weight portion medical material obtains after extraction.
Preparation of the present invention is injection and oral formulations.
Specifically: injection of the present invention comprises: little liquid drugs injection, injectable powder and infusion solutions.Described oral formulations comprises: all acceptable dosage forms on the pharmaceuticss such as tablet, oral cavity disintegration tablet, capsule, soft capsule, microcapsule, granule, pill, powder, drop pill, slow releasing preparation, controlled release preparation, oral liquid, soft extract, extractum or membrane.
The preparation method of the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease of the present invention: get Radix Salviae Miltiorrhizae, add entry or alcoholic solution after the pulverizing, soak, extract, merge extractive liquid, filters refining, or again medicinal residues can be added alcoholic solution or water heating extraction, filter and make with extra care, merge refining filtrate, further refining mother solution or extractum or the solid Radix Salviae Miltiorrhizae extract of being condensed into; Get Folium Ginkgo, pulverize the back and add ethanol, soak, backflow or percolation extract, and merge extractive liquid, concentrates, and filters, and mother solution or extractum or solid Folium Ginkgo extract are made with extra care, are condensed into to filtrate, with the Radix Salviae Miltiorrhizae extract mix homogeneously, makes different preparations then again.
Specifically: the preparation method of the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease of the present invention is: get Radix Salviae Miltiorrhizae, pulverize the back and add 4～15 times of water or alcoholic solution, soaked 2～12 hours, extract, merge extractive liquid,, concentrate or carry out suitably refiningly, further make extractum or solid Radix Salviae Miltiorrhizae extract; Get Folium Ginkgo, pulverize the back and add 3～20 times of alcoholic solution, soak, backflow or percolation extract, merge extractive liquid, reclaims ethanol, concentrates or carries out suitably refining, further make extractum or solid Folium Ginkgo extract, mix evenly with Radix Salviae Miltiorrhizae extractum or extract again, make different preparations then.
More specifically: preparation method of the present invention is: get Radix Salviae Miltiorrhizae, add the water of 4～15 times of amounts after the coarse pulverization, soaked 2～12 hours, heating extraction 1～5 time, each 0.5～2 hour, merge extractive liquid,, filter, filtrate concentrates, and adds 1%～8% gelatin solution, stir evenly, cold preservation is spent the night, and filters, filtrate concentrates, add ethanol and make and contain the alcohol amount and reach 50%～90%, cold preservation is spent the night, and filters, filtrate recycling ethanol, add the injection water, cold preservation is spent the night, and filters, filtrate is boiled the back and is added 0.05%～0.2% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Get Folium Ginkgo, add 40%～80% ethanol of 3～12 times of amounts, reflux, extract, 1～5 time, each 0.5～3 hour, merge backflow, filter, filtrate recycling ethanol concentrates, add the water for injection dissolving, filter, filtrate is crossed macroporous adsorptive resins or polyamide column and silicagel column, with 0～15% ethanol elution impurity, 40～90% ethanol elutions of 2～8 times of weight resins of reuse, eluent reclaims ethanol and concentrates, and adds the injection water, and cold preservation is spent the night, filter, filtrate is boiled the needle-use activated carbon of back adding 0.05%～0.2%, keeps little and boils 30 minutes, cold slightly filtration, filtrate for later use is made different preparations then respectively.
Lyophilized injectable powder in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, and 4 ℃ of cold preservations are spent the night, and filters.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol adds the injection water to 750ml when relative density is 50 ℃ 1.05～1.10, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, filter, mannitol is added the injection water be mixed with 120mg/ml solution,, filter with above-mentioned filtrate mixing, packing, pre-freeze temperature-45～-40 ℃, pre-freeze time 6～8h;-40～-35 ℃ of evacuation keep 6～8h; Be warming up to-30～-25 ℃ again, keep 6～8h; Be warming up to-20～-15 ℃, keep 6～8h; Be warming up to-10～-5 ℃, keep 3～5h; Be warming up to 0 ℃, keep 3～5h; Be warming up to 15～20 ℃, keep 1～3h; Be warming up to 25～30 ℃, keep 1～3h, be warming up to 35～40 ℃, keep 1～3h, promptly.
Aqueous injection in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, and 4 ℃ of cold preservations are spent the night, and filters.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol adds the injection water to 750ml when relative density is 50 ℃ 1.05～1.10, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add the adjustment of injection water, divide to install to pacify and cut open bottle, seal sterilization promptly.
Glucose infusion liquid agent in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, and 4 ℃ of cold preservations are spent the night, and filters.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol adds the injection water to 750ml when relative density is 50 ℃ 1.05～1.10, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add in an amount of process glucose solution that boils, with the water for injection dilution promptly.
Sodium chloride infusion solution in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, and 4 ℃ of cold preservations are spent the night, and filters.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol adds the injection water to 750ml when relative density is 50 ℃ 1.05～1.10, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add in an amount of process sodium chloride solution that boils, with the water for injection dilution promptly.
Capsule in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add 1～2% magnesium stearate, mixing incapsulates promptly.
Drop pill in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the Macrogol 4000 of 1～1.5 times of medicated powder weight, merge evenly, splash in the liquid paraffin promptly.
Soft capsule in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the soybean oil of 0.8～1.2 times of medicated powder weight and 2～5% Cera Flava, mix homogeneously is pressed into soft capsule.
Tablet in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the carboxymethyl starch sodium of an amount of microcrystalline Cellulose and 1%～6%, mixing, tabletting.
Oral cavity disintegration tablet in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add 5%～8% polyvinylpolypyrrolidone PVPP and an amount of mannitol, compacting is in flakes.
Oral liquid in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, the Radix Salviae Miltiorrhizae concentrated solution; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol is when relative density is 50 ℃ 1.03～1.05, the water dissolution that adds 4 times of medical material weight, filter, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, the Folium Ginkgo concentrated solution, above-mentioned Radix Salviae Miltiorrhizae filtrate merges, adding simple syrup and potassium sorbate are an amount of behind the mixing, and mixing adds water to full dose, fill, sterilization promptly gets oral liquid.
Slow-releasing microcapsule agent in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, it is even to join in 3%～5% the gelatin solution DL, is the flocculating agent sedimentation with metabisulfite solution, microcapsule incapsulates promptly.
Granule in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add an amount of stevioside and dextrin, make granule, be drying to obtain.
Pill in the preparation of the present invention prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the water pill promptly.
Among the we, Radix Salviae Miltiorrhizae promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing; The Semen Ginkgo relieving pain and activating blood circulation, both compatibility Synergistics.Compared with prior art, compatibility of the present invention is simple, and is rationally feasible, and good effect has no side effect, and the preparation method of different dosage form is provided, and wide application has enlarged the scope of application.The applicant found through experiments preparation of the present invention and can play improvement cardiac muscle and brain tissue metabolism, increase coronary artery and brain vessel blood, improve the effect of blood confessions such as cardiac muscle and cerebral tissue, for treating cardiovascular and cerebrovascular disease such as coronary heart disease, angina pectoris, arrhythmia, cerebral thrombosis, alzheimer disease etc. curative effect is preferably arranged, simultaneously can human body immunity improving power, resist the disease takes place, the compare combination preparation better efficacy of existing Radix Salviae Miltiorrhizae, Semen Ginkgo and the Radix Astragali, reduced cost, reduce dosage, improved safety.
Compared with prior art, the applicant has carried out perfect medicament composing prescription compatibility experiment, not merely is simple superposition; By antiplatelet aggregation test, inhibition mouse tail thrombotest and the anti-protective effect test that lacks sugared anoxia to the In vitro culture myocardial cell injury; to these two kinds of medicines (Semen Ginkgo: Radix Salviae Miltiorrhizae) by 6: 1,6: 2,6: 5,6: 6,5: 6,2: 6 and 1: 6 totally 7 combination and compatibilities prescriptions; carried out the prescription screening test of system; found that by force and consumption is lower, that is to say that both compatibilities can reach potentiation antidotal effect with the pharmacological action of Semen Ginkgo 18g and Radix Salviae Miltiorrhizae 15g combination (6: 5) prescription.In preparation process, find, the salvianolic acid less stable, make freeze-dried powder, both can guarantee clinical efficacy, can avoid simultaneously liquid drugs injection again because phenomenons such as the hydrolysis that long-time placement is taken place, oxidation, generation precipitations, make preparation more stable, help the storage of preparation, solid preparation is convenient to transportation simultaneously.In the process of development powder pin, find that the key of this product is a moulding process, particularly the kind of the ph value of dosing, caffolding agent, liquor strength, freeze-dry process condition.Can molding because the kind of caffolding agent, freeze-dry process condition directly influence product, and the liquor strength of this product is high more, mouldability is poor more; But if reduce liquor strength, then clinical usage quantity strengthens.Through experiment, this product selection mannitol is every milliliter as freeze dried caffolding agent, liquor strength and contains crude drug amount 8.25g, and following process conditions :-45 ℃, and behind the pre-freeze 8h, the beginning evacuation, and be warming up to-40 ℃, keep 10h; Be warming up to-30 ℃, keep 10h; Be warming up to-20 ℃, keep 10h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 15 ℃, keep 3h; Be warming up to 25 ℃, keep 3h; Be warming up to 35 ℃, keep 3h, make ideal preparation.Pharmaceutical preparation of the present invention, with respect to the independent preparation of Radix Salviae Miltiorrhizae, Semen Ginkgo better efficacy not only, and use and carry all easily, the preparation method of multiple different oral formulations is provided, be suitable for different crowd and use, heart disease and hyperpietic also can take for a long time.Find in the process of development oral formulations: the use of adjuvant is its key point: the former medicated powder in this preparation has certain moisture, former medicated powder viscosity is poor simultaneously, be difficult for presswork, therefore also to make mixed material have certain viscosity when solving former medicated powder lubricity, so just increase the difficulty of making tablet; And the main active of Radix Salviae Miltiorrhizae is a phenols in this preparation, and it is closely bound up how to improve stability and the drop pill substrate of effective ingredient in drop pill; Contain a large amount of liposoluble constituents in the Semen Ginkgo extrac simultaneously, more increased the filling difficulty in the preparation capsule city of medicated powder, make content uniformity bigger, make the very big difficulty of capsule increase for this raw material, in order to overcome above technological difficulties, can only improve the lubricity of former medicated powder by adjuvant, reduce its adhesiveness; Microcapsule can reach the effect of controlled release, chief reason is that the capsule material can the enclose effective ingredient, control its rate of release, but the envelop rate of Chinese medicine is on the low side is technological difficulties of puzzlement research worker always, and the effective ingredient in the Radix Salviae Miltiorrhizae in this preparation (Radix Salviae Miltiorrhizae total phenols) is not very stable, the condition that need control when carrying out enclose is very strict, therefore more increase the difficulty of this preparation research, grope by thinking over trial test, the principal element that we find to influence its envelop rate is the consumption of gelatin, so we seek the concentration of only gelatin by experiment in 3%～5% scope.
The applicant has carried out a series of experiments, can prove that medicine provided by the invention has effective effect;
Experimental example 1: drug regimen compatibility foundation
We are by antiplatelet aggregation test, inhibition mouse tail thrombotest and the anti-protective effect test that lacks sugared anoxia to the In vitro culture myocardial cell injury; to these two kinds of medicines (Semen Ginkgo: Radix Salviae Miltiorrhizae) by 6: 1,6: 2,6: 5,6: 6,5: 6,2: 6 and 1: 6 totally 7 combination and compatibilities prescriptions; carried out the prescription screening test of system; found that by force and consumption is lower, be the formal prescription of this project so determine that this ratio is write out a prescription with the pharmacological action of Semen Ginkgo 18g and Radix Salviae Miltiorrhizae 15g combination (6: 5) prescription.
The red prescription research conclusion of injection Fructus Pruni
| Formula number | Prescription is formed and ratio | The screening and assessment index | |||||
| Semen Ginkgo (g) | Radix Salviae Miltiorrhizae (g) | Ratio | Platelet suppression ratio (%) | Thrombosis suppression ratio (%) | The test of cultivation myocardial cell injury | ||
| LDH reduces % | CK reduces % | ||||||
| ????1 | ??18 | 3 | 6∶1 | 56.8％ | 52.7％ | 48.9％ | 49.6％ |
| ????2 ????3 ????4 ????5 ????6 ????7 | ????18 ????18 ????18 ????15 ????6 ????3 | ????6 ????15 ????18 ????18 ????18 ????18 | ????6∶2 ????6∶5 ????6∶6 ????5∶6 ????2∶6 ????1∶6 | ????59.6％ ????63.1％ ????77.6％ ????76.7％ ????50.7％ ????41.2％ | ??55.4％ ??66.2％ ??73.2％ ??74.1％ ??62.4％ ??50.3％ | ????42.7％ ????55.7％ ????61.6％ ????59.3％ ????55.2％ ????39.9％ | ????58.4％ ????62.8％ ????69.4％ ????67.4％ ????60.8％ ????41.8％ |
(2) affirmation and the side's of tearing open research conclusion of Semen Ginkgo 18g and Radix Salviae Miltiorrhizae 15g combination prescription effectiveness
Drug efficacy study through system shows; after two medication combined application; the obvious synergistic effect is arranged aspect blood circulation promoting and blood stasis dispelling; aspect the treatment cerebral ischemia obvious synergistic effect is being arranged also; can obviously increase simultaneously the afterload of blood flow coronarius, reduction Ischemic Heart, the increase of antagonism myocardial oxygen consumption, thus the better protection ischemic myocardium.
Injection gingko-red sage (hereinafter to be referred as " Fructus Pruni pellet ") prescription research conclusion
| Pilot project | The red group of injection Fructus Pruni | The Semen Ginkgo group | The Radix Salviae Miltiorrhizae group |
| The test promoting blood circulation and removing blood stasis that resists myocardial ischemia of dog local cerebral ischemia model test GBI model test | Effect significantly (model 21.68%) ischemic percentage 12.70% successful significantly reduces infarct size and significantly reduces myocardium enzyme and significantly resist electrocardio to change descend contraction and the diastolic function effect of remarkable protection ischemic myocardium of obvious antagonism cardiac output remarkable | Successful ischemic percentage 14.86% successful obviously reduces infarct size and obviously reduces myocardium enzyme and obviously resist electrocardio and change and to have the effective trend effect of trend of antagonism obvious | General ischemic percentage 13.42% successful of effect obviously reduces infarct size and obviously reduces myocardium enzyme and obviously resist electrocardio and change and to have the effective trend effect of trend of antagonism obvious |
(3) affirmation and the side's of tearing open research conclusion of the full property of Semen Ginkgo 18g and Radix Salviae Miltiorrhizae 15g combination prescription
The red heavy dose of 27.5～6.88g/kg continuous intravenous infusion of injection Fructus Pruni administration 90 days and drug withdrawal 14 days, Beagle dog routine urinalysis, routine blood test, electrolyte, PT and aPTT, biochemistry, electrocardiogram, bone marrow examination etc. are not all had obviously influence, also do not have obvious retardance toxic reaction.Its safe dose is 27.5g/kg and following dosage.
1. acute toxicity test: the result shows that the maximum dosage-feeding of the red mice of injection Fructus Pruni, rat tail vein injection and lumbar injection is respectively 330g/kg and 412.5g/kg, maximum administration multiple is respectively 600 times and 750 times of 60kg body weight adult clinical vein instillation day dosage, shows that the red safe dose scope of injection Fructus Pruni is bigger.
2. rat long term toxicity test conclusion:
Successive administration 90 days and 14 days rat long term toxicity tests of drug withdrawal result show, injection Fructus Pruni pellet mainly can influence blood system (reduce RBC, HGB and HCT, rising WBC, HGB, MCH, MCHC, RDWS prolong PT and aPTT), can recover after the drug withdrawal, not see obvious retardance toxic reaction.The side of tearing open studies show that, compound recipe is for producing new overt toxicity reaction, 44g/kg and following be its safe dose scope.
A. ordinary circumstance and body weight: male Mus of high dose group and the female Mus body weight of Radix Salviae Miltiorrhizae group obviously or significantly descend (P＜0.05 or P＜0.01).
B. the routine blood test base electrolyte is checked: administration 90 days, and middle dosage group MID, GRA, RBC obviously raise (P＜0.05), and LY% obviously reduces (P＜0.05), and low dose group WBC, LYM, HGB, MCH, MCHC, RDWs be obviously rising (P＜0.05) all.The side of tearing open studies show that, the whole rat WBC of Radix Salviae Miltiorrhizae group male and female, LYM, MCH, MCHC, RDWs obvious or significantly raise (P＜0.05 or P＜0.01), RBC obviously reduces (P＜0.05), the whole rat WBC of Folium Ginkgo group male and female, GRA, GR%, HCT, MCV, MCHC obviously or significantly raise (P＜0.05 or P＜0.01), HGB, MCH obviously or extremely significantly reduce (P＜0.05 or P＜0.001), these change in the normal physiologic values scope, infer that to have a function of promoting blood circulation to disperse blood clots relevant with these product.Other index is rising or the reduction that is dispersed in, and is not dose dependent, so infer to be the normal physiological fluctuation of animal.
Drug withdrawal 14 days, middle dosage group MCV, RDWs obviously raise (P＜0.05), and low dose group GR%, RBC, HGB, HCT obviously reduce (P＜0.05), MCV, RDWs obviously raise (P＜0.05).The side of tearing open studies show that, the whole rat HGB of Radix Salviae Miltiorrhizae group male and female, RDWs obviously reduce (P＜0.05), MCV obviously raise (P＜0.05), the whole rat HGB of Folium Ginkgo group male and female, RBC, HCT obviously or significantly reduce (P＜0.05 or P＜0.01), MCV, MCH, RDWs obviously or significantly raise (P＜0.05 or P＜0.001), and these change in the normal physiologic values scope.Other index is rising or the reduction that is dispersed in, and is not dose dependent, so infer to be the normal physiological fluctuation of animal.C.PT and aPTT check: administration 90 days, the whole rats of male and female high, medium and low and two groups of PT in the side of tearing open and obvious respectively or remarkable raise (P＜0.05 or P＜0.01) of aPTT.The high, medium and low dosage group of male rat PT, aPTT all extremely significantly or significantly raise (P＜0.001 or P＜0.01), female rats high dose group aPTT significantly raise (P＜0.01).Supposition is the result of the long-term a large amount of administrations of activating blood and removing stasis drug.Drug withdrawal 14 days, each organizes equal no significant difference (P＞0.05).
D. serum electrolyte checking: 90 days high, normal, basic and two groups of male Mus K in the side of tearing open of administration
+, Na
+Be the remarkable reduction of dose dependent and obviously increase (P＜0.01 or P＜0.05), but all in the normal physiologic values scope, and its maximum reduction rate＜1.5%, so think no clinical meaning.Two groups of the 14 days visible senior middle school's low dose group of drug withdrawal and the sides of tearing open thereof, Cl
-Be the reduction (P＜0.05～P＜0.01) of dose dependent, but all in the normal physiologic values scope, and its maximum reduction rate only 3.13%, so think no clinical meaning.Some other variation that is dispersed in does not have obvious dose dependent, and supposition is the biological value fluctuation.
E. liver function test: show no obvious abnormalities.
F. kidney function test: show no obvious abnormalities.
G. blood glucose and serum cholesterol inspection: show no obvious abnormalities.
H. system becomes celestial and the organ index inspection: show no obvious abnormalities.
I. histopathologic examination: show no obvious abnormalities.
The selection of experimental example 2 dosing pH value
For adapting to the Human Physiology needs, also to consider the character of each constituents in the medicinal liquid simultaneously, when dosing, need suitably adjust the pH value of medicinal liquid.Select the Radix Salviae Miltiorrhizae total phenol content as evaluation index.
Test method and result: after feeding intake and handle by recipe quantity by above-mentioned condition, with Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, filter, add water to 1000ml, adjust pH, when the different pH value that reaches shown in the following table, boil the back standing over night, observe the variation of appearance character under different pH condition.Experimental result sees Table.
The investigation of dosing pH value
| Sequence number | ??1??????2??????3??????4??????5??????6??????7??????8??????9 |
| Dosing pH boils the pH outward appearance | 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 3.5 4.1 4.4 5.1 5.6 6.1 6.5 6.7 7.2 the no significant change color burn of precipitation occurs |
The result shows, medicinal liquid boils the back pH value and occurs precipitating at the sample 5.0 below, and pH value is obviously deepened in the color sample more than 6.5, and pH value is that 5.0～6.5 medicinal liquid is relatively stable, and outward appearance does not have significant change.Below its total phenol content is measured, be the results are shown in Table.
The situation of change table of index components before and after pH value is regulated
| Sequence number | Dosing pH | Total phenol content during dosing (%) | Boil back pH | Boil back total phenol content (%) |
| ????1 ????2 ????3 ????4 | ????5.0 ????5.5 ????6.0 ????6.5 | ????24.45 ????24.45 ????24.45 ????24.45 | ????4.6 ????5.2 ????5.6 ????5.9 | ????23.73 ????23.17 ????23.50 ????23.16 |
As seen from table, medicinal liquid is being adjusted the pH value front and back, the not too big variation of index components Radix Salviae Miltiorrhizae total phenol content.The changes of contents of the appearance character of comprehensive above-mentioned medicinal liquid and Radix Salviae Miltiorrhizae total phenols, the pH value of medicinal liquid is transferred between 5.0～6.5 when determining dosing.
The investigation of experimental example 3 freeze-dry process
(1) screening of caffolding agent kind
The caffolding agent kind influences the molding of freeze-dried powder, so at first this is screened.Get the medicinal liquid that contains crude drug 8.25g/ml, mix with caffolding agent mannitol, glucose and lactose solution respectively, 0.22 μ m membrane filtration postlyophilization, every XiLin bottle-packaging solution 3ml.Freeze dryer: Edwards SNL-3200 freezer dryer (the thermoelectric Thermo of the U.S.).Lyophilisation condition :-45 ℃, behind the pre-freeze 8h, the beginning evacuation, and be warming up to-40 ℃, keep 10h; Be warming up to-30 ℃, keep 10h; Be warming up to-20 ℃, keep 10h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 15 ℃, keep 3h; Be warming up to 25 ℃, keep 3h; Be warming up to 35 ℃, keep 3h.The result is as showing:
The screening of caffolding agent kind
| The caffolding agent kind | The caffolding agent solution concentration | Caffolding agent: medicinal liquid (V: V) | The finished product outward appearance |
| The glucose lactose | ????150mg/ml ? ? ????150mg/ml | ????1∶2 ????1∶1 ????2∶1 ????1∶2 ????1∶1 | The atrophy atrophy atrophy atrophy of partly subsiding |
| The blank medicinal liquid of mannitol | ? ? ??150mg/ml ? ? | ????2∶1 ????1∶2 ????1∶1 ????2∶1 ????3ml | The atrophy atrophy molding atrophy of partly subsiding |
As seen from table, in the adjuvant that is screened, under the identical situation of other conditions, the effect of mannitol is better than other two kinds of adjuvants, therefore adopts mannitol as freeze dried caffolding agent.
(2) investigation of liquor strength
The medicinal liquid of getting variable concentrations and 150mg/ml mannitol solution according to the form below volume ratio respectively mix, and filter postlyophilization, and every cillin bottle loading amount is 3ml.Lyophilisation condition :-45 ℃, behind the pre-freeze 8h, the beginning evacuation, and be warming up to-40 ℃, keep 10h; Be warming up to-30 ℃, keep 10h; Be warming up to-20 ℃, keep 10h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 15 ℃, keep 3h; Be warming up to 25 ℃, keep 3h; Be warming up to 35 ℃, keep 3h.Result such as following table:
The liquor strength screening
| Numbering | Liquor strength (containing crude drug amount g/ml) | Mannitol: medicinal liquid (v: v) | Color and luster | Profile |
| ????1 ????2 ????3 ????4 ????5 ????6 ????7 ????8 ????9 | ????4.125 ????4.125 ????4.125 ????8.25 ????8.25 ????8.25 ????16.5 ????16.5 ????16.5 | ????2∶1 ????1∶1 ????1∶2 ????2∶1 ????1∶1 ????1∶2 ????2∶1 ????1∶1 ????1∶2 | Yellowish yellow yellow deep yellow | Good better subsiding than good part has atrophy color and luster inequality, the atrophy atrophy of subsiding |
By table as seen, liquor strength is high more, and mouldability is poor more; When liquor strength is containing crude drug amount 8.25g/ml when following, the sample mouldability is better, and color and luster and profile are all more satisfactory.If reduce liquor strength, then clinical usage quantity strengthens.Take all factors into consideration the mouldability and the clinical application amount of finished product, select liquor strength to be every milliliter and contain crude drug amount 8.25g.
(3) caffolding agent consumption screening
The mannitol solution (100mg/ml, 120mg/ml and 140mg/ml) of variable concentrations is mixed in varing proportions with the medicinal liquid that contains crude drug 8.25g/ml, filter, every cillin bottle loading amount is 3ml, lyophilization.Lyophilisation condition :-45 ℃, behind the pre-freeze 8h, the beginning evacuation, and be warming up to-40 ℃, keep 10h; Be warming up to-30 ℃, keep 10h; Be warming up to-20 ℃, keep 10h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 15 ℃, keep 3h; Be warming up to 25 ℃, keep 3h; Be warming up to 35 ℃, keep 3h.The result is as showing:
The screening of mannitol consumption
| Numbering | Mannitol concentration (mg/ml) | Mannitol: medicinal liquid (v: v) | Color and luster | Profile | Solubility | Clarity |
| ??1 ??2 ??3 | ????100 ? | ????2∶1 ????1∶1 ????1∶2 | Yellowish yellow | The inhomogeneous atrophy of subsiding | Well carefully | Up to specification up to specification |
| ??4 ??5 ??6 | ? ????120 ? | ????2∶1 ????1∶1 ????1∶2 | Yellowish Huang | The atrophy of subsiding well | Well carefully | Up to specification up to specification |
| ??7 ??8 ??9 | ? ????140 ? | ????2∶1 ????1∶1 ????1∶2 | Yellowish Huang | The good part atrophy of subsiding | Well carefully | Up to specification up to specification |
As seen from table, when the ratio of caffolding agent consumption and medicinal liquid was 2: 1, the sample character was better than other two ratios, so the ratio of mannitol solution and medicinal liquid is defined as 2: 1; And for the sample of same ratio, the sample that with the mannitol concentration is 120mg/ml and 140mg/ml is relatively good, but take all factors into consideration the consumption and the clinical dose of adjuvant, finally selecting mannitol concentration is 120mg/ml, and the volume ratio of mannitol solution and medicinal liquid is 2: 1.
(4) lyophilization conditional filtering
Lyophilization is a veryer long dry run, needs to consume a large amount of energy.An ideal lyophilisation condition not only can be saved a large amount of energy, can also shorten man-hour simultaneously, so we are optimized screening to existing lyophilisation condition.The actual conditions screening sees Table:
The lyophilization conditional filtering
| Time (h) temperature (℃) | Condition I | Condition II | Old terms | Cold-trap |
| -45 (pre-freezes) | ????8 | ????- | ????8 | Keep-70 ℃ |
| -40 (pre-freezes) | ????- | ????8 | ????- | |
| -40 (evacuation) | ????8 | ????- | ????10 | |
| -35 (evacuation) | ????- | ????8 | ????- | |
| -30 (evacuation) | ????8 | ????- | ????10 | |
| -25 (evacuation) | ????- ? | ????8 ? | ????- ? | |
| -20 (evacuation) | ????8 | ????- | ????10 | |
| -15 (evacuation) | ????- | ????8 | ????- | |
| -10 (evacuation) | ????5 | ????- | ????5 | |
| 0 (evacuation) | ????5 | ????5 | ????5 | |
| 15 (evacuation) | ????2 | ????4 | ????3 | |
| 25 (evacuation) | ????2 | ????4 | ????3 | |
| 35 (evacuation) | ????2 | ????4 | ????3 |
Experimental result shows: a large amount of atrophy phenomenons appear in condition II gained sample, finished product appearance character that condition I and former lyophilisation condition make and the equal conformance with standard of moisture.Consider the practical situation of production, the condition I that the finally selected overall time spent is short, i.e. lyophilization condition is: pre-freeze temperature-45 ℃, pre-freeze time 8h;-40 ℃ of evacuation keep 8h; Be warming up to-30 ℃ again, keep 8h; Be warming up to-20 ℃, keep 8h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 15 ℃, keep 2h; Be warming up to 25 ℃, keep 2h, be warming up to 35 ℃, keep 2h, get product.
Experimental example 4: oral formulations adjuvant screening
(1) tablet
Former medicated powder in the XINGDAN ZHIJI has certain moisture, and former medicated powder viscosity is poor simultaneously, is difficult for presswork.Therefore also to make mixed material have certain viscosity when solving former medicated powder lubricity, so just increased the difficulty of said preparation, so we investigate to following adjuvant.
| Adjuvant | 15% starch | 15% microcrystalline Cellulose | 15% cane sugar powder |
| Angle of repose | 37 degree | 32 degree | 39 degree |
| Hardness | Loose | Moderate | By force |
From result of upper experiment as can be seen, selecting microcrystalline Cellulose for use is adjuvant, not only can reduce the angle of repose of mixed powder, increases its flowability, but also can make the hardness of tablet moderate, helps the molding of sample.
(2) drop pill: Traditional Chinese Medicine Dropping Pill than higher, should be considered the dissolution characteristics of former medicated powder to the requirement of medicine, also will consider the paste-forming rate of medical material simultaneously, and medicated powder increases taking dose too much; Cross the low paste-forming rate that reduces, the dose of drop pill is reduced, but can lose too much effective ingredient like this, thereby reduce curative effect of medication, in order to take into account curative effect of medication, also will make sample drop make ball as far as possible simultaneously, we investigate drug matrices.
| Medicated powder amount (g) | Matrix species | Substrates quantity (g) | Evaluation index | |
| Mixing uniformity | Hardness | |||
| ????20.0 ????20.0 | ????PEG4000 ????PEG6000 | ????30.0 ????30.0 | The energy mixing, no bubble energy mixing has a large amount of bubbles and caking | Moderate not enough |
From top experimental data as can be seen, two kinds of substrate all can make the medicated powder mixing, but PEG6000 lumps sample easily, and the drop pill hardness of making is not enough, the main active of Radix Salviae Miltiorrhizae is a phenols in the XINGDAN ZHIJI simultaneously, not only improves the stability of effective ingredient by using substrate PEG4000, and effective ingredient is absorbed rapidly, the bioavailability height, we select PEG4000 for use therefore to take all factors into consideration the sample character.
(3) capsule
The extract paste-forming rate of this product is higher, and medicated powder has certain moisture; Contain a large amount of liposoluble constituents in the Semen Ginkgo extrac simultaneously, more increased the filling difficulty of medicated powder, make content uniformity bigger, make the very big difficulty of capsule increase for this raw material.In order to overcome above technological difficulties, we screen and investigate following adjuvant, and result of the test is as follows:
| Adjuvant | 2% magnesium stearate | 2% Pulvis Talci | 2% stearic acid |
| Angle of repose | 34 degree | 37 degree | 38 degree |
| Content uniformity | Qualified | Defective | Defective |
From top result as can be seen, have only magnesium stearate could really improve the lubricity of former medicated powder in three kinds of lubricants, reduce its adhesiveness, make mixed powder be more conducive to flow and load capsule, therefore the consideration magnesium stearate.
(4) microcapsule
Microcapsule can reach the effect of controlled release, and chief reason is that the capsule material can the enclose effective ingredient, controls its rate of release.But the envelop rate of Chinese medicine is on the low side is technological difficulties of puzzlement research worker always, and the effective ingredient in the Radix Salviae Miltiorrhizae in the XINGDAN ZHIJI (Radix Salviae Miltiorrhizae total phenols) is not very stable, the condition that need control when carrying out enclose is very strict, therefore more increase the difficulty of this preparation research, grope by thinking over trial test, the principal element that we find to influence its envelop rate is the consumption of gelatin, so we design following test and investigate.
| Gelatin concentration (%) | ??1 | ??3 | ??5 | ??7 |
| The microcapsule form | Flat not whole, inhomogeneous | Rounding, even | Rounding, even | Rounding, even |
| Total phenols envelop rate (%) | ??70 | ??85 | ??89 | ??91 |
From top data as can be seen, along with the increase of gelatin consumption, the form of microcapsule is good more, and microcapsule increases to some extent to the envelop rate of Radix Salviae Miltiorrhizae total phenols simultaneously.Under the situation that guarantees envelop rate and microcapsule outward appearance, guarantee to reduce the gelatin consumption simultaneously, our preferred concentration is in 3%～5% scope.
Experimental example 5: pharmacological evaluation
(1) to the protective effect of rat experiment cerebral ischemia.
Get 750 of healthy male Wistar rats, animal is divided into 7 groups at random, it is Sham-operated control group, model control group, pharmaceutical composition 0.1g/kg group of the present invention, pharmaceutical composition 0.2g/kg group of the present invention, matched group (Radix Salviae Miltiorrhizae, Semen Ginkgo, Radix Astragali combination) 0.1g/kg, matched group (Radix Salviae Miltiorrhizae, Semen Ginkgo, Radix Astragali combination) 0.2g/kg, nimodipine 10mg/kg group, every group 10, behind the intravenous administration 10 minutes, rat is fixing after with 12% chloral hydrate 350mg/kg intraperitoneal injection of anesthesia, cut a kerf at rat right external auditory canal and eye corner of the eyes center line, separating muscle, remove zygomatic arch, expose the temporo precoila, bore a microcephalia window at the about 2mm of cheekbone and squamosal bone joint front lower place place, expose middle cerebral artery MCA, provoke with fine needle, electricity is blocked the MCA of inferior cerebral vein lower edge with fixed attention.The layer-by-layer suture wound steams again and raises then.Sham operated rats is except that not blocking the MCA the same model group of all the other operating procedures.Postoperative 12 hours is intravenous administration once more.8 hours after surgery and 24 hours respectively, animal is carried out behavior scoring.Full marks are 11 minutes, and mark is high more, and the behavior disorder of animal is serious more.In addition in postoperative in the time of 24 hours with the animal sacrificed by decapitation, open cranium and get brain, claim that wet brain is heavy, roasting to constant weight in 110 ℃ of baking boxs then, claim dried brain heavy.Calculate brain water content (water %=(wet quality-dry mass)/wet quality * 100%).Results model group rat after surgery 8, tangible behavior change all appears in 24h, and the nervous symptoms of pharmaceutical composition of the present invention and nimodipine group rat all has improve (seeing Table) in various degree; And each administration group all can significantly reduce degree of cerebral edema (seeing Table).By contrast, pharmaceutical composition high dose group of the present invention is more excellent than nimodipine to the protective effect of rat cerebral ischemia.
The present composition is to the influence of rat behavior defect level
| Group | ????n | The behavior scoring value | |
| ????8h | ????24h | ||
| Sham-operation group model group Nimodipine 10mg/kg high dose group 0.2g/kg low dose group 0.1g/kg contrast high dose group 0.2g/kg contrast low dose group 0.1g/kg | ????10 ????10 ????10 ????10 ????10 ????10 ????10 | ????0 ????9.0±1.2 ????6.9±1.1** ????5.5±1.2** ????6.9±0.9** ????5.8±1.1** ????7.1±0.7** | ????0 ????7.7±1.0 ????6.0±1.3* ????5.0±1.0** ????5.8±0.7* ????5.4±1.2** ????6.3±0.7* |
Compare * P＜0.05, * * P＜0.01 with model group
The present composition is to the influence of cerebral edema
| Group | ?n | Brain water content (%) |
| Sham-operation group model group Nimodipine 10mg/kg high dose group 0.2g/kg low dose group 0.1g/kg contrast high dose group 0.2g/kg contrast low dose group 0.1g/kg | ?10 ?10 ?10 ?10 ?10 ?10 ?10 | ????76.25±0.66* ????81.23±0.78 ????77.69±0.55* ????77.00±0.71** ????77.12±0.80* ????78.10±0.71** ????78.42±0.79* |
Compare * P＜0.05, * * P＜0.01 with model group
(2) ligation causes the influence of myocardial infarction to rat coronary artery
48 of male Wistar rats, animal is divided into 6 groups at random, be Sham-operated control group, model control group, pharmaceutical composition injectable powder 0.15g/kg of the present invention group, pharmaceutical composition injectable powder 0.3g/kg of the present invention group, matched group (injectable powder of Radix Salviae Miltiorrhizae, Semen Ginkgo extrac preparation) 0.15g/kg, 8 every group of matched group (the powder pin of Radix Salviae Miltiorrhizae, Semen Ginkgo extrac preparation) 0.3g/kg, each group is gastric infusion respectively, and every day 1 time for three days on end.1h after the last administration is with pentobarbital anesthesia, tracheal intubation, artificial respiration.Open breast in the 3rd～4 intercostal,, cause occlusive arteria coronaria district myocardial infarction apart from coronary artery outlet 5mm place's ligation left anterior descending coronary artery.Behind 4h, use the electromagnetic flowmeter determination coronary artery blood flow, and measure the infarcted region area percentage.The results are shown in Table, the coronary flow of medication group significantly increases, and the infarcted region area obviously reduces (comparing P with model control group all＜0.01).
Influence to coronary artery blood flow and infarct size after the rat coronary artery ligation
| Group | Coronary flow (ml/min.100g) | Cerebral infarction dead band area percentage (%) |
| Sham-operation group model group high dose group 0.30g/k low dose group 0.15g/kg contrast high dose group 0.30g/kg contrast low dose group 0.15g/kg | ????58.05±2.32 ????31.19±1.73 ????43.86±3.53** ????38.37±2.11** ????41.86±3.51** ????37.40±2.13** | ????- ????15.18±1.20 ????5.45±0.96** ????6.14±0.84** ????5.66±0.93** ????6.20±0.89** |
Compare * * P＜0.01 with model group
By experiment as can be known, pharmaceutical composition of the present invention all has the obvious treatment effect to experimental cardiac muscle and cerebral ischemia animal model, can significantly improve nervous symptoms and reduction degree of cerebral edema that cerebral ischemia causes, coronary occlusion is caused that the myocardial ischemia situation can significantly increase coronary flow, and obviously reducing myocardial infarction district area, effect is better than directly using the preparation of Radix Salviae Miltiorrhizae extract, Semen Ginkgo extrac preparation.
Concrete embodiment:
Embodiments of the invention 1: Radix Salviae Miltiorrhizae 50g, Folium Ginkgo 60g
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, and 4 ℃ of cold preservations are spent the night, and filters.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol adds the injection water to 750ml when relative density is 50 ℃ 1.05～1.10, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, filter, mannitol is added the injection water be mixed with 120mg/ml solution,, filter with above-mentioned filtrate mixing, packing, pre-freeze temperature-45～-40 ℃, pre-freeze time 6～8h;-40～-35 ℃ of evacuation keep 6～8h; Be warming up to-30～-25 ℃ again, keep 6～8h; Be warming up to-20～-15 ℃, keep 6～8h; Be warming up to-10～-5 ℃, keep 3～5h; Be warming up to 0 ℃, keep 3～5h; Be warming up to 15～20 ℃, keep 1～3h; Be warming up to 25～30 ℃, keep 1～3h, be warming up to 35～40 ℃, keep 1～3h, promptly get lyophilized injectable powder, three times on the one, each one, injection is used.
Embodiments of the invention 2: Radix Salviae Miltiorrhizae 50g, Folium Ginkgo 60g
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, and 4 ℃ of cold preservations are spent the night, and filters.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol adds the injection water to 750ml when relative density is 50 ℃ 1.05～1.10, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add the adjustment of injection water, divide to install to pacify and cut open bottle, seal sterilization and promptly get aqueous injection.
Embodiments of the invention 3: Radix Salviae Miltiorrhizae 50 weight portions, Folium Ginkgo 60 weight portions
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, and 4 ℃ of cold preservations are spent the night, and filters.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol adds the injection water to 750ml when relative density is 50 ℃ 1.05～1.10, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add in an amount of process glucose solution that boils, and promptly get the glucose infusion liquid agent with the water for injection dilution.
Embodiments of the invention 4: Radix Salviae Miltiorrhizae 50 weight portions, Folium Ginkgo 60 weight portions
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, and 4 ℃ of cold preservations are spent the night, and filters.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol adds the injection water to 750ml when relative density is 50 ℃ 1.05～1.10, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, and filter.Add after filtrate is boiled by W/V and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add in an amount of process sodium chloride solution that boils, and promptly get with the water for injection dilution and promptly get the sodium chloride infusion solution.
Embodiments of the invention 5: Radix Salviae Miltiorrhizae 50 weight portions, Folium Ginkgo 60 weight portions
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add 1～2% magnesium stearate, mixing incapsulates and promptly gets capsule.
Embodiments of the invention 6: Radix Salviae Miltiorrhizae 50 weight portions, Folium Ginkgo 60 weight portions
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the Macrogol 4000 of 1～1.5 times of medicated powder weight, merge evenly, splash into and promptly get drop pill in the liquid paraffin.
Embodiments of the invention 7: Radix Salviae Miltiorrhizae 50 weight portions, Folium Ginkgo 60 weight portions
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the soybean oil of 0.8～1.2 times of medicated powder weight and 2～5% Cera Flava, mix homogeneously is pressed into soft capsule.
Embodiments of the invention 8: 50 parts of Radix Salviae Miltiorrhizaes, 60 parts of Folium Ginkgos; Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the carboxymethyl starch sodium of an amount of microcrystalline Cellulose and 1%～6%, mixing, tabletting promptly gets tablet.
Embodiments of the invention 9: 50 parts of Radix Salviae Miltiorrhizaes, 60 parts of Folium Ginkgos
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add 5%～8% polyvinylpolypyrrolidone PVPP and an amount of mannitol, compacting promptly gets oral cavity disintegration tablet in flakes.
Embodiments of the invention 10: 50 parts of Radix Salviae Miltiorrhizaes, 60 parts of Folium Ginkgos
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, the Radix Salviae Miltiorrhizae concentrated solution; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol is when relative density is 50 ℃ 1.03～1.05, the water dissolution that adds 4 times of medical material weight, filter, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, the Folium Ginkgo concentrated solution, above-mentioned Radix Salviae Miltiorrhizae filtrate merges, adding simple syrup and potassium sorbate are an amount of behind the mixing, and mixing adds water to full dose, fill, sterilization promptly gets oral liquid.
Embodiments of the invention 11: 50 parts of Radix Salviae Miltiorrhizaes, 60 parts of Folium Ginkgos
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, it is even to join in 3%～5% the gelatin solution DL, is the flocculating agent sedimentation with metabisulfite solution, microcapsule incapsulates and promptly gets the slow-releasing microcapsule agent.
Embodiments of the invention 12: 50 parts of Radix Salviae Miltiorrhizaes, 60 parts of Folium Ginkgos
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add an amount of stevioside and dextrin, make granule, be drying to obtain granule.
Embodiments of the invention 13: 50 parts of Radix Salviae Miltiorrhizaes, 60 parts of Folium Ginkgos
Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter.Filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the water pill and promptly get pill.
80 parts of embodiments of the invention 14 Radix Salviae Miltiorrhizaes, 20 parts of Folium Ginkgos
Get Radix Salviae Miltiorrhizae, add the water of 4 times of amounts after the coarse pulverization, soaked heating extraction 0.5 hour 2 hours, merge extractive liquid, filters, and filtrate concentrates, and adds 1% gelatin solution, stir evenly, cold preservation is spent the night, and filters, and filtrate concentrates, add ethanol and make and contain the alcohol amount and reach 50%, cold preservation is spent the night, and filters filtrate recycling ethanol, add the injection water, cold preservation is spent the night, and filters, and filtrate is boiled the back and added 0.05% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Get Folium Ginkgo, add 40% ethanol of 3 times of amounts, reflux, extract, 0.5 hour, merge backflow, filter, filtrate recycling ethanol concentrates, and adds the water for injection dissolving, filter, filtrate is crossed macroporous adsorptive resins or polyamide column and silicagel column, water eluting impurity, 40% ethanol elution of 2 times of weight resins of reuse, eluent reclaims ethanol and concentrates, add the injection water, cold preservation is spent the night, and filters, filtrate is boiled the needle-use activated carbon of back adding 0.05%%, keep little and boiled 30 minutes, cold slightly filtration, filtrate, add syrup, promptly get soft extract.
20 parts of embodiments of the invention 15 Radix Salviae Miltiorrhizaes, 80 parts of Folium Ginkgos
Get Radix Salviae Miltiorrhizae, add the water of 15 times of amounts after the coarse pulverization, soaked heating extraction 5 times 12 hours, each 2 hours, merge extractive liquid, filtered, and filtrate concentrates, the gelatin solution of adding 8% stirs evenly, and cold preservation is spent the night, and filters, filtrate concentrates, and adds ethanol and makes and contain the alcohol amount and reach 90%, and cold preservation is spent the night, and filters, filtrate recycling ethanol adds the injection water, and cold preservation is spent the night, and filters, filtrate is boiled the back and is added 0.2% needle-use activated carbon, keeps little and boils 30 minutes, cold slightly filtration, filtrate for later use; Get Folium Ginkgo, add 80% ethanol of 12 times of amounts, reflux, extract, 5 times, each 3 hours, merge backflow, filter, filtrate recycling ethanol concentrates, and adds the water for injection dissolving, filters, filtrate is crossed macroporous adsorptive resins or polyamide column and silicagel column, with 15% ethanol elution impurity, and 90% ethanol elution of 8 times of weight resins of reuse, eluent reclaims ethanol and concentrates, add the injection water, cold preservation is spent the night, and filters, filtrate is boiled the needle-use activated carbon of back adding 0.2%, keep little and boiled 30 minutes, cold slightly filtration, merging filtrate, dry, pulverize, granulate, promptly get granule.
20 parts of embodiments of the invention 16 Radix Salviae Miltiorrhizae extracts, 80 parts of Folium Ginkgo extract
Get Radix Salviae Miltiorrhizae, pulverize the back and add 4 times of water or alcoholic solution, soaked 2 hours, extract, merge extractive liquid, concentrates or carries out suitably making with extra care, and further makes extractum or solid Radix Salviae Miltiorrhizae extract; Get Folium Ginkgo, pulverize the back and add 3 times of alcoholic solution, soak, reflux or the percolation extraction, merge extractive liquid, reclaims ethanol, concentrates or carries out suitably refining, further make extractum or solid Folium Ginkgo extract, mix evenly with Radix Salviae Miltiorrhizae extractum or extract again, filter, add the adjustment of injection water, divide to install to pacify and cut open bottle, seal sterilization and promptly get aqueous injection.
80 parts of embodiments of the invention 17 Radix Salviae Miltiorrhizae extracts, 20 parts of Folium Ginkgo extract
Get Radix Salviae Miltiorrhizae, pulverize the back and add 15 times of water or alcoholic solution, soaked 12 hours, extract, merge extractive liquid, concentrates or carries out suitably making with extra care, and further makes extractum or solid Radix Salviae Miltiorrhizae extract; Get Folium Ginkgo, pulverize the back and add 20 times of alcoholic solution, soak, reflux or the percolation extraction, merge extractive liquid, reclaims ethanol, concentrates or carries out suitably refining, further make extractum or solid Folium Ginkgo extract, mix evenly with Radix Salviae Miltiorrhizae extractum or extract again, filter, add water for injection, sterilization gets infusion solutions.
Embodiments of the invention 18: 50 parts of Radix Salviae Miltiorrhizae extracts, 60 parts of Folium Ginkgo extract; Get Radix Salviae Miltiorrhizae, add entry or alcoholic solution after the pulverizing, soak, extract, merge extractive liquid, filters and makes with extra care, or again medicinal residues can be added alcoholic solution or water heating extraction, filter and make with extra care, merge refining filtrate, further refining mother solution or extractum or the solid Radix Salviae Miltiorrhizae extract of being condensed into; Get Folium Ginkgo, pulverize the back and add ethanol, soak, backflow or percolation extract, and merge extractive liquid, concentrates, and filters, and mother solution or extractum or solid Folium Ginkgo extract are made with extra care, are condensed into to filtrate, again with the Radix Salviae Miltiorrhizae extract mix homogeneously, add distilled water, promptly get oral liquid.
Embodiments of the invention 19: 50 parts of Radix Salviae Miltiorrhizae extracts, 60 parts of Folium Ginkgo extract; Radix Salviae Miltiorrhizae is added 10 times of water gagings decoct 2 times, each 1 hour, merge decoction liquor, filter, filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V calculating, stirs evenly, 4 ℃ of cold preservations are spent the night, filter, relative density was 1.15～1.20 when filtrate was concentrated into 50 ℃, added ethanol and made and contain the alcohol amount and reach 80%, 4 ℃ of cold preservations are spent the night, and filter; Relative density is 1.05～1.10 during filtrate recycling ethanol to 50 ℃, adds the injection water to 750ml, i.e. 5g crude drug/ml, and 4 ℃ of cold preservations are spent the night, and filter; Filtrate is boiled the back and is added 0.1% needle-use activated carbon by W/V calculating, keeps little and boils 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, and each 1 hour, filter, filtrate recycling ethanol to 50 ℃ relative density is 1.03～1.05, adds the water for injection dissolving of 4 times of medical material weight, filters.Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol to 50 ℃ relative density 1.10～1.15 adds the injection water to 200ml, i.e. 22.5g crude drug/ml, 4 ℃ of cold preservations are spent the night, and filter; Filtrate is boiled the back and is added 0.1% needle-use activated carbon by W/V calculating, keeps little and boils 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, filter, mannitol is added the injection water be mixed with 120mg/ml solution,, filter with above-mentioned filtrate mixing, packing, pre-freeze temperature-45～-40 ℃, pre-freeze time 6～8h;-40～-35 ℃ of evacuation keep 6～8h; Be warming up to-30～-25 ℃ again, keep 6～8h; Be warming up to-20～-15 ℃, keep 6～8h; Be warming up to-10～-5 ℃, keep 3～5h; Be warming up to 0 ℃, keep 3～5h; Be warming up to 15～20 ℃, keep 1～3h; Be warming up to 25～30 ℃, keep 1～3h, be warming up to 35～40 ℃, keep 1～3h, promptly get injectable powder.
Claims (21)
1, a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease is characterized in that: calculate according to parts by weight, it by 80～20 parts of 20～80 parts of Radix Salviae Miltiorrhizaes and Folium Ginkgos through extract, refining and add suitable adjuvant and be made; Or form by corresponding weight portion medical material Radix Salviae Miltiorrhizae extract that after extracting, obtains and the prepared from extraction of ginkgo leaves that corresponding weight portion medical material obtains after extraction.
2, according to the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 1, it is characterized in that: calculate according to parts by weight, it is made for 60 parts by 50 parts of Radix Salviae Miltiorrhizaes and Folium Ginkgo, or is formed by corresponding weight portion medical material Radix Salviae Miltiorrhizae extract that obtains after extracting and the prepared from extraction of ginkgo leaves that corresponding weight portion medical material obtains after extraction.
3, according to the Chinese medicine preparation of claim 1 or 2 described treatment cardiovascular and cerebrovascular diseases, it is characterized in that: preparation of the present invention is injection and oral formulations.
4, according to the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 3, it is characterized in that: injection comprises: little liquid drugs injection, injectable powder and infusion solutions.
5, according to the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 3, it is characterized in that: oral formulations comprises: all acceptable dosage forms on the pharmaceuticss such as tablet, oral cavity disintegration tablet, capsule, soft capsule, microcapsule, granule, pill, powder, drop pill, slow releasing preparation, controlled release preparation, oral liquid, soft extract, extractum, membrane.
6, as the preparation method of the Chinese medicine preparation of any described treatment cardiovascular and cerebrovascular disease among the claim 1-5, it is characterized in that: get Radix Salviae Miltiorrhizae, add entry or alcoholic solution after the pulverizing, soak, extract, merge extractive liquid,, filter and make with extra care, or again medicinal residues can be added alcoholic solution or water heating extraction, filter refining, merge refining filtrate, further refining mother solution or extractum or the solid Radix Salviae Miltiorrhizae extract of being condensed into; Get Folium Ginkgo, pulverize the back and add ethanol, soak, backflow or percolation extract, and merge extractive liquid, concentrates, and filters, and mother solution or extractum or solid Folium Ginkgo extract are made with extra care, are condensed into to filtrate, with the Radix Salviae Miltiorrhizae extract mix homogeneously, makes different preparations then again.
7, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 6, it is characterized in that: get Radix Salviae Miltiorrhizae, pulverize the back and add 4～15 times of water or alcoholic solution, soaked 2～12 hours, extract, merge extractive liquid, concentrates or carries out suitably refiningly, further makes extractum or solid Radix Salviae Miltiorrhizae extract; Get Folium Ginkgo, pulverize the back and add 3～20 times of alcoholic solution, soak, backflow or percolation extract, merge extractive liquid, reclaims ethanol, concentrates or carries out suitably refining, further make extractum or solid Folium Ginkgo extract, mix evenly with Radix Salviae Miltiorrhizae extractum or extract again, make different preparations then.
8, preparation method according to the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 7 is characterized in that: get Radix Salviae Miltiorrhizae, add the water of 4～15 times of amounts after the coarse pulverization, soaked heating extraction 1～5 time, each 0.5～2 hour 2～12 hours, merge extractive liquid, filters, and filtrate concentrates, the gelatin solution of adding 1%～8% stirs evenly, and cold preservation is spent the night, filter, filtrate concentrates, and adds ethanol and makes and contain the alcohol amount and reach 50%～90%, cold preservation is spent the night, filter, filtrate recycling ethanol adds the injection water, cold preservation is spent the night, filter, filtrate is boiled the back and is added 0.05%～0.2% needle-use activated carbon, keeps little and boils 30 minutes, cold slightly filtration, filtrate for later use; Get Folium Ginkgo, add 40%～80% ethanol of 3～12 times of amounts, reflux, extract, 1～5 time, each 0.5～3 hour, merge backflow, filter, filtrate recycling ethanol concentrates, add the water for injection dissolving, filter, filtrate is crossed macroporous adsorptive resins or polyamide column and silicagel column, with 0～15% ethanol elution impurity, 40～90% ethanol elutions of 2～8 times of weight resins of reuse, eluent reclaims ethanol and concentrates, and adds the injection water, and cold preservation is spent the night, filter, filtrate is boiled the needle-use activated carbon of back adding 0.05%～0.2%, keeps little and boils 30 minutes, cold slightly filtration, filtrate for later use is made different preparations then respectively.
9, preparation method according to the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the lyophilized injectable powder in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, filtrate concentrates, add 5% gelatin solution and make gelatine content reach 1% by W/V, stir evenly, 4 ℃ of cold preservations are spent the night, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter, filtrate recycling ethanol adds the injection water to 750ml, i.e. 5g crude drug/ml when relative density is 50 ℃ 1.05～1.10,4 ℃ of cold preservations are spent the night, filter, add by W/V after filtrate is boiled and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, and each 1 hour, filter, filtrate recycling ethanol adds the water for injection dissolving of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters; Supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, filter, add by W/V after filtrate is boiled and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, filter, mannitol is added the injection water be mixed with 120mg/ml solution,, filter with above-mentioned filtrate mixing, packing, pre-freeze temperature-45～-40 ℃, pre-freeze time 6～8h;-40～-35 ℃ of evacuation keep 6～8h; Be warming up to-30～-25 ℃ again, keep 6～8h; Be warming up to-20～-15 ℃, keep 6～8h; Be warming up to-10～-5 ℃, keep 3～5h; Be warming up to 0 ℃, keep 3～5h; Be warming up to 15～20 ℃, keep 1～3h; Be warming up to 25～30 ℃, keep 1～3h, be warming up to 35～40 ℃, keep 1～3h, promptly.
10, preparation method according to the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the aqueous injection in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, filtrate concentrates, add 5% gelatin solution and make gelatine content reach 1% by W/V, stir evenly, 4 ℃ of cold preservations are spent the night, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter, filtrate recycling ethanol adds the injection water to 750ml, i.e. 5g crude drug/ml when relative density is 50 ℃ 1.05～1.10,4 ℃ of cold preservations are spent the night, filter, add by W/V after filtrate is boiled and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filter, filtrate recycling ethanol is when relative density is 50 ℃ 1.03～1.05, the water for injection dissolving that adds 4 times of medical material weight, filter, supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, filter, add by W/V after filtrate is boiled and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add the adjustment of injection water, divide to install to pacify and cut open bottle, seal sterilization promptly.
11, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the glucose infusion liquid agent in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, filtrate concentrates, adding 5% gelatin solution makes gelatine content reach 1% by W/V, stir evenly, 4 ℃ of cold preservations are spent the night, and filter.When filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, add ethanol and make and contain the alcohol amount and reach 80%, 4 ℃ of cold preservation and spend the night, filter, filtrate recycling ethanol adds the injection water to 750ml, i.e. 5g crude drug/ml when relative density is 50 ℃ 1.05～1.10,4 ℃ of cold preservations are spent the night, filter, add by W/V after filtrate is boiled and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filter, filtrate recycling ethanol is when relative density is 50 ℃ 1.03～1.05, the water for injection dissolving that adds 4 times of medical material weight, filter, supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, filter, add by W/V after filtrate is boiled and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add in an amount of process glucose solution that boils, with the water for injection dilution promptly.
12, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the sodium chloride infusion solution in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, and each 1 hour, merge decoction liquor, filter.Filtrate concentrates, and adds 5% gelatin solution and makes gelatine content reach 1% by W/V, stirs evenly, 4 ℃ of cold preservations are spent the night, and filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol adds the injection water to 750ml, i.e. 5g crude drug/ml when relative density is 50 ℃ 1.05～1.10,4 ℃ of cold preservations are spent the night, and filter, and add by W/V after filtrate is boiled and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filter, filtrate recycling ethanol is when relative density is 50 ℃ 1.03～1.05, the water for injection dissolving that adds 4 times of medical material weight, filter, supernatant is crossed the D-101 macroporous adsorptive resins, earlier with the water for injection of 4 times of weight resins and 15% ethanol elution impurity of 4 times of weight resins, 80% alcohol desorption of 4 times of weight resins of reuse, collect stripping liquid, decompression recycling ethanol adds the injection water to 200ml, i.e. 22.5g crude drug/ml during to 50 ℃ of relative densities 1.10～1.15,4 ℃ of cold preservations are spent the night, filter, add by W/V after filtrate is boiled and calculate 0.1% needle-use activated carbon, keep little and boiled 30 minutes, cold slightly filtration, filtrate for later use; Folium Ginkgo water liquid, Radix Salviae Miltiorrhizae water liquid mix homogeneously, adjust pH 5.0～6.5 boils, and 4 ℃ of cold preservations are spent the night, and filter, and add in an amount of process sodium chloride solution that boils, with the water for injection dilution promptly.
13, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the capsule in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters, filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add 1～2% magnesium stearate, mixing incapsulates promptly.
14, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the drop pill in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters, filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the Macrogol 4000 of 1～1.5 times of medicated powder weight, merge evenly, splash in the liquid paraffin promptly.
15, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the soft capsule in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters, filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the soybean oil of 0.8～1.2 times of medicated powder weight and 2～5% Cera Flava, mix homogeneously is pressed into soft capsule.
16, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the tablet in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters, filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the carboxymethyl starch sodium of an amount of microcrystalline Cellulose and 1%～6%, mixing, tabletting.
17, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the oral cavity disintegration tablet in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters, filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add 5%～8% polyvinylpolypyrrolidone PVPP and an amount of mannitol, compacting is in flakes.
18, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the oral liquid in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, the Radix Salviae Miltiorrhizae concentrated solution; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters, filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, get the Folium Ginkgo concentrated solution, above-mentioned Radix Salviae Miltiorrhizae filtrate merges, and adding simple syrup and potassium sorbate are an amount of behind the mixing, mixing, add water to full dose, fill, sterilization promptly gets oral liquid.
19, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the slow-releasing microcapsule agent in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters.Filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, and when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, it is even to join in 3%～5% the gelatin solution DL, is the flocculating agent sedimentation with metabisulfite solution, microcapsule incapsulates promptly.
20, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the granule in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters, filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add an amount of stevioside and dextrin, make granule, be drying to obtain.
21, according to the preparation method of the Chinese medicine preparation of the described treatment cardiovascular and cerebrovascular disease of claim 8, it is characterized in that: the pill in the described preparation prepares like this: Radix Salviae Miltiorrhizae adds 10 times of water gagings and decocts 2 times, each 1 hour, merge decoction liquor, filter, when filtrate is concentrated into relative density and is 50 ℃ 1.15～1.20, adding ethanol makes the alcohol amount of containing reach 80%, 4 ℃ of cold preservation to spend the night, filter, filtrate recycling ethanol when relative density is 50 ℃ 1.05～1.10, dry Radix Salviae Miltiorrhizae extract; Folium Ginkgo adds 60% alcohol reflux 3 times of 10 times of amounts, each 1 hour, filters, filtrate recycling ethanol adds the water dissolution of 4 times of medical material weight when relative density is 50 ℃ 1.03～1.05, filters, when filtrate is concentrated into 50 ℃ of relative densities 1.10～1.15, dry Folium Ginkgo extract; With above-mentioned Radix Salviae Miltiorrhizae extract and Semen Ginkgo extrac mix homogeneously, add the water pill promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510056634XA CN100542548C (en) | 2004-04-07 | 2005-04-06 | A kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410022288 CN1562216A (en) | 2004-04-07 | 2004-04-07 | Preparation of Chinese traditional medicine for curing cardiovascular and cerebrovascular disease and preparation method |
| CN200410022288.9 | 2004-04-07 | ||
| CNB200510056634XA CN100542548C (en) | 2004-04-07 | 2005-04-06 | A kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1689637A true CN1689637A (en) | 2005-11-02 |
| CN100542548C CN100542548C (en) | 2009-09-23 |
Family
ID=35345591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510056634XA Expired - Fee Related CN100542548C (en) | 2004-04-07 | 2005-04-06 | A kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100542548C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101274013B (en) * | 2007-03-27 | 2011-06-08 | 高海 | Prescription medicine for curing senile dementia and preparation |
| CN103989757A (en) * | 2014-06-17 | 2014-08-20 | 史克勇 | Traditional Chinese medicinal composition and application thereof |
| CN106491706A (en) * | 2016-11-03 | 2017-03-15 | 云南中科本草科技有限公司北京分公司 | Ginkgo leaf capsule of red sage root |
-
2005
- 2005-04-06 CN CNB200510056634XA patent/CN100542548C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101274013B (en) * | 2007-03-27 | 2011-06-08 | 高海 | Prescription medicine for curing senile dementia and preparation |
| CN103989757A (en) * | 2014-06-17 | 2014-08-20 | 史克勇 | Traditional Chinese medicinal composition and application thereof |
| CN106491706A (en) * | 2016-11-03 | 2017-03-15 | 云南中科本草科技有限公司北京分公司 | Ginkgo leaf capsule of red sage root |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100542548C (en) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1824177A (en) | Medicinal composition for treating hypertension, its preparation method and use | |
| CN1927331A (en) | Chinese medicine preparation for curing chronic heart failure | |
| CN1689637A (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN1562186A (en) | Preparation of Chinese traditional medicine for curing Illness of Cardiac cerebral ischemia and preparation method | |
| CN1698820A (en) | Dripping pills with jaundice eliminating liver protecting functions and its preparation method | |
| CN1720948A (en) | Dripping pills of lllicium henryi dripping pills and method for preparing the same | |
| CN1704113A (en) | Chinese traditional medicinal preparation containing red sange root and safflower for treating cardiovascular and cerebrovascular diseases and preparing process thereof | |
| CN1701810A (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN101032534A (en) | Method of preparing jiubiying total saponins and the application thereof | |
| CN1636581A (en) | Safflower medicine composition and its prepn process and use | |
| CN1626145A (en) | Medication for treating cough | |
| CN1891266A (en) | Chinese medicine oral disintegrating tablet for treating angina pectoris, and its preparing method | |
| CN1586516A (en) | Medicinal composition for treating cardiocerebral vasculr disease and its preparing method | |
| CN1456198A (en) | Angong hemostatics | |
| CN1626121A (en) | Preparation of Chinese traditional medicine for treating coronary heart disease and angina | |
| CN1602917A (en) | 'Shengmai' formulation and its preparation process | |
| CN1939390A (en) | Medicinal composition and its making method | |
| CN1733071A (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN1891249A (en) | Chinese medicine preparation for treating cardio-cerebrovascular disease and its preparing method | |
| CN1562216A (en) | Preparation of Chinese traditional medicine for curing cardiovascular and cerebrovascular disease and preparation method | |
| CN1895314A (en) | A lyophilized powder for injection containing Notoginseng radix total saponin with good appearance and shatter resistance, and its preparation method | |
| CN1733039A (en) | Compound preparation of breviscapinum for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN1626129A (en) | Medicine for treating obstruction of qi in the chest and heartache | |
| CN1118278C (en) | Application of ursolic acid in medicine for treating viral hepatitis | |
| CN1733061A (en) | Chinese medicinal preparation with astragalus root and erigeron breviscapus and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090923 Termination date: 20150406 |
|
| EXPY | Termination of patent right or utility model |